Literature DB >> 12574120

Glycoprotein G isoforms from some alphaherpesviruses function as broad-spectrum chemokine binding proteins.

Neil A Bryant1, Nick Davis-Poynter, Alain Vanderplasschen, Antonio Alcami.   

Abstract

Mimicry of host chemokines and chemokine receptors to modulate chemokine activity is a strategy encoded by beta- and gammaherpesviruses, but very limited information is available on the anti-chemokine strategies encoded by alphaherpesviruses. The secretion of chemokine binding proteins (vCKBPs) has hitherto been considered a unique strategy encoded by poxviruses and gammaherpesviruses. We describe a family of novel vCKBPs in equine herpesvirus 1, bovine herpesvirus 1 and 5, and related alphaherpesviruses with no sequence similarity to chemokine receptors or other vCKBPs. We show that glycoprotein G (gG) is secreted from infected cells, binds a broad range of chemokines with high affinity and blocks chemokine activity by preventing their interaction with specific receptors. Moreover, gG also blocks chemokine binding to glycosaminoglycans, an interaction required for the correct presentation and function of chemokines in vivo. In contrast to other vCKBPs, gG may also be membrane anchored and, consistently, we show chemokine binding activity at the surface of cells expressing full-length protein. These alphaherpesvirus vCKBPs represent a novel family of proteins that bind chemokines both at the membrane and in solution.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574120      PMCID: PMC145452          DOI: 10.1093/emboj/cdg092

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

Review 1.  Modulating chemokines: more lessons from viruses.

Authors:  A S Lalani; J W Barrett; G McFadden
Journal:  Immunol Today       Date:  2000-02

Review 2.  Chemokines: a new classification system and their role in immunity.

Authors:  A Zlotnik; O Yoshie
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

Review 3.  Viral subversion of the immune system.

Authors:  D Tortorella; B E Gewurz; M H Furman; D J Schust; H L Ploegh
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

4.  Viral antichemokines: from pathogenesis to drug discovery.

Authors:  P M Murphy
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

5.  A herpes simplex virus 1 recombinant lacking the glycoprotein G coding sequences is defective in entry through apical surfaces of polarized epithelial cells in culture and in vivo.

Authors:  L C Tran; J M Kissner; L E Westerman; A E Sears
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

6.  Variability of the glycoprotein G gene in clinical isolates of herpes simplex virus type 1.

Authors:  E Rekabdar; P Tunbäck; J A Liljeqvist; T Bergström
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

7.  Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action.

Authors:  V van Berkel; J Barrett; H L Tiffany; D H Fremont; P M Murphy; G McFadden; S H Speck; I V Virgin HW
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

8.  Recombinant IFN-alpha (2b) increases the expression of apoptosis receptor CD95 and chemokine receptors CCR1 and CCR3 in monocytoid cells.

Authors:  D Zella; O Barabitskaja; L Casareto; F Romerio; P Secchiero; M S Reitz; R C Gallo; F F Weichold
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

9.  A broad spectrum secreted chemokine binding protein encoded by a herpesvirus.

Authors:  C M Parry; J P Simas; V P Smith; C A Stewart; A C Minson; S Efstathiou; A Alcami
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

Review 10.  Viral mechanisms of immune evasion.

Authors:  A Alcami; U H Koszinowski
Journal:  Immunol Today       Date:  2000-09
View more
  36 in total

1.  An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain.

Authors:  M Begoña Ruiz-Argüello; Vincent P Smith; Gabriele S V Campanella; Françoise Baleux; Fernando Arenzana-Seisdedos; Andrew D Luster; Antonio Alcami
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

2.  rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy.

Authors:  Lan Wu; Tian-gui Huang; Marcia Meseck; Jennifer Altomonte; Oliver Ebert; Katsunori Shinozaki; Adolfo García-Sastre; John Fallon; John Mandeli; Savio L C Woo
Journal:  Hum Gene Ther       Date:  2008-06       Impact factor: 5.695

Review 3.  Alphaherpesviruses and chemokines: pas de deux not yet brought to perfection.

Authors:  Gerlinde R Van de Walle; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

4.  In vitro characterization of EHV-4 gG-deleted mutant.

Authors:  Walid Azab; Abuelyazeed El-Sheikh; Azza Abdel-Gawad
Journal:  Virus Genes       Date:  2011-09-29       Impact factor: 2.332

Review 5.  Subversion of cytokine networks by virally encoded decoy receptors.

Authors:  Megan L Epperson; Chung A Lee; Daved H Fremont
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

6.  Exponential enhancement of oncolytic vesicular stomatitis virus potency by vector-mediated suppression of inflammatory responses in vivo.

Authors:  Jennifer Altomonte; Lan Wu; Li Chen; Marcia Meseck; Oliver Ebert; Adolfo García-Sastre; John Fallon; Savio L C Woo
Journal:  Mol Ther       Date:  2007-12-11       Impact factor: 11.454

7.  Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor.

Authors:  Jennifer M Alexander-Brett; Daved H Fremont
Journal:  J Exp Med       Date:  2007-12-10       Impact factor: 14.307

8.  CCL3 and viral chemokine-binding protein gg modulate pulmonary inflammation and virus replication during equine herpesvirus 1 infection.

Authors:  Gerlinde R Van de Walle; Kaori Sakamoto; Nikolaus Osterrieder
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

9.  Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells.

Authors:  J Altomonte; L Wu; M Meseck; L Chen; O Ebert; A Garcia-Sastre; J Fallon; J Mandeli; S L C Woo
Journal:  Cancer Gene Ther       Date:  2008-10-10       Impact factor: 5.987

Review 10.  The role of chemokines during herpes simplex virus-1 infection.

Authors:  Todd R Wuest; Daniel J J Carr
Journal:  Front Biosci       Date:  2008-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.